Kyung‐Hee Kim

This study identifies and characterizes three new CYPs in T. litoralis that catalyze specific oxidations of four MIA skeletons, expanding understanding of MIA biosynthesis.

The paper identifies genetic modifiers of somatic CAG expansion and clinical phenotypes in Huntington's disease, revealing shared and tissue-specific effects on disease timing and pathogenic processes.

This study develops personalized CRISPR-Cas9 strategies to specifically inactivate the mutant BAG3 allele in MFM6 patients, demonstrating their feasibility for regenerative medicine.

This study shows that the length of uninterrupted CAG repeats, not the encoded polyglutamine segment, determines Huntington's disease onset, and DNA maintenance genes modify this process.